SCHEMBL7006695

SCHEMBL7006695

Cc1ccc(-c2cncnc2C#N)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERBB2 P04626 1/20 0.47
SLC9A1 P19634 1/20 0.40
LRRK2 Q5S007 1/20 0.39
DGAT1 O75907 1/20 0.38
GRM5 P41594 1/20 0.38
CYP11B2 P19099 4/20 0.38
CYP11B1 P15538 3/20 0.38
LMNA P02545 1/20 0.37
PKM P14618 1/20 0.37
KDM4E B2RXH2 4/20 0.36
ALDH1A1 P00352 3/20 0.36
CYP1A2 P05177 2/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2D6 P10635 2/20 0.36
CYP2C19 P33261 2/20 0.36
CYP2A6 P11509 1/20 0.36
HPGD P15428 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
PPARG P37231 1/20 0.36
NCOA2 Q15596 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14555850 0.83 ERBB2 (0.47) ERBB2SLC9A1LRRK2LMNAKDM4E
SCHEMBL7010761 0.79 CYP1A2 (0.34) ERBB2DGAT1CYP11B2CYP11B1KDM4E
SCHEMBL7679638 0.74 ERBB2 (0.45) ERBB2LRRK2GRM5CYP11B2KDM4E
SCHEMBL18357050 0.73 ERBB2 (0.41) ERBB2LRRK2GRM5KDM4EALDH1A1
SCHEMBL7006231 0.73 DGAT1 (0.67) SLC9A1LRRK2DGAT1KDM4EALDH1A1
SCHEMBL7015277 0.73 RPS6KA3 (0.44) SLC9A1DGAT1GRM5LMNAPKM
SCHEMBL7013819 0.73 DGAT1 (0.41) SLC9A1DGAT1GRM5LMNAPKM
SCHEMBL7012436 0.72 CDK1 (0.46) ERBB2LRRK2GRM5CYP11B2CYP11B1
SCHEMBL7676386 0.71 LRRK2 (0.51) LRRK2CYP11B2CYP11B1LMNAKDM4E
SCHEMBL15985325 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1327631-A2 Fused heterocyclic compounds, their production and use as angiotensin II antagonists Takeda Chemical Industries, Ltd. (JP) 2003-07-16 EP disclosed
EP-0518033-B1 Fused heterocyclic compounds, their production and use TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2003-07-02 EP disclosed
US-5389641-A Fused heterocyclic compounds, having angiotensin II antagonistic activity TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1995-02-14 US disclosed
EP-0518033-A1 Fused heterocyclic compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1992-12-16 EP disclosed